Collplant Biotechnologies Stock Price on October 10, 2024
| CLGN Stock | USD 4.26 0.12 2.90% |
Below is the normalized historical share price chart for Collplant Biotechnologies extending back to May 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Collplant Biotechnologies stands at 4.26, as last reported on the 26th of November, with the highest price reaching 4.30 and the lowest price hitting 4.15 during the day.
If you're considering investing in Collplant Stock, it is important to understand the factors that can impact its price. Collplant Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.084, which signifies that the company had a -0.084% return per unit of risk over the last 3 months. Collplant Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Collplant Biotechnologies' Risk Adjusted Performance of (0.06), standard deviation of 3.24, and Mean Deviation of 2.43 to double-check the risk estimate we provide.
At this time, Collplant Biotechnologies' Common Stock Shares Outstanding is very stable compared to the past year. As of the 26th of November 2024, Total Stockholder Equity is likely to grow to about 29.8 M, while Liabilities And Stockholders Equity is likely to drop about 18.2 M. . At this time, Collplant Biotechnologies' Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.18, while Price To Sales Ratio is likely to drop 6.31. Collplant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of January 2018 | 200 Day MA 5.0258 | 50 Day MA 4.3481 | Beta 0.483 |
Collplant |
Sharpe Ratio = -0.084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLGN |
Estimated Market Risk
| 3.31 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Collplant Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Collplant Biotechnologies by adding Collplant Biotechnologies to a well-diversified portfolio.
Price Book 2.2877 | Enterprise Value Ebitda (5.97) | Price Sales 68.8267 | Shares Float 7.8 M | Wall Street Target Price 12.5 |
Related Headline
Keros Therapeutics Headline on 10th of October 2024
Disposition of 875 shares by Jennifer Lachey of Keros Therap... by Jennifer Lachey
Filed transaction by Keros Therapeutics Officer Chief Scientific Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Collplant Biotechnologies Valuation on October 10, 2024
It is possible to determine the worth of Collplant Biotechnologies on a given historical date. On October 10, 2024 Collplant was worth 4.52 at the beginning of the trading date compared to the closed value of 4.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Collplant Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Collplant Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Collplant Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Collplant Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 4.63 | 4.63 | 4.52 | 4.55 | 3,630 | |
10/10/2024 | 4.52 | 4.81 | 4.45 | 4.56 | 17,817 |
| 4.60 | 4.73 | 4.46 | 4.67 | 2,599 |
| Backtest Collplant Biotechnologies | | | Collplant Biotechnologies History | | | Collplant Biotechnologies Valuation | Previous | Next |
Collplant Biotechnologies Trading Date Momentum on October 10, 2024
| On October 11 2024 Collplant Biotechnologies was traded for 4.67 at the closing time. The top price for the day was 4.73 and the lowest listed price was 4.46 . The trading volume for the day was 2.6 K. The trading history from October 11, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 2.41% . The overall trading delta against the current closing price is 9.21% . |
Collplant Biotechnologies Fundamentals Correlations and Trends
By evaluating Collplant Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Collplant Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Collplant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Collplant Biotechnologies Stock history
Collplant Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Collplant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Collplant Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Collplant Biotechnologies stock prices may prove useful in developing a viable investing in Collplant Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.4 M | 12 M | |
| Net Loss | -19.5 M | -20.4 M |
Collplant Biotechnologies Quarterly Net Working Capital |
|
Collplant Biotechnologies Stock Technical Analysis
Collplant Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Collplant Biotechnologies Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Collplant Biotechnologies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Collplant Biotechnologies November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Collplant Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collplant Biotechnologies shares will generate the highest return on investment. By undertsting and applying Collplant Biotechnologies stock market strength indicators, traders can identify Collplant Biotechnologies entry and exit signals to maximize returns
Collplant Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Collplant Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Collplant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Collplant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.06 | Quarterly Revenue Growth (0.98) | Return On Assets (0.34) | Return On Equity (0.62) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.